In the News

FDA Finally Hitting Sweet Spot with Off-Label Oversight, Law360

November 21, 2018

Morgan Lewis partner Stephen Mahinka is quoted in a Law360 article about FDA Commissioner Scott Gottlieb’s efforts to postpone enforcement of off-label marketing restrictions for large pharmaceutical companies. Mahinka shares in the article that the FDA’s moderate approach to changing enforcement procedures is laying “the groundwork for the change internally, so that it takes.”

Read the full Law360 article >>